Healthy Behaviors Learning Task and Sleep (NAP)
Overweight/Obese Population

About this trial
This is an interventional treatment trial for Overweight/Obese Population focused on measuring healthy, BMI, weight loss, sleep, healthy sleeper, overweight, obese
Eligibility Criteria
Inclusion Criteria:
- Age between 20 and 55, inclusive
- Body mass index ≥ 25
- Nonsmoker and non-nicotine user for a minimum of the past 6 months
- Not currently using recreational drugs
- Desire to lose weight
- Difficulty losing weight in the past
- AUDIT: <3 women, <4 men (note: score of 4 is okay if both items 2 and 3=0)
- Pittsburgh Sleep Quality Index questionnaire score <8
- Insomnia Severity Index questionnaire score <10
- Epworth Sleepiness Scale <10
- Below the clinical cutoff for Restless Leg Syndrome
- Full sleep cycle between 8:00pm and 9:00am at least 6 days per week
- Apnea hypopnea index <15, as measured by the Nox-T3
Exclusion Criteria:
- Current diagnosis of diabetes mellitus (type 1 or type 2)
- History of major medical disease impacting study
- Significant unstable medical morbidity within the past 6 months
- Significant unstable psychiatric disorder within the past 6 months
- Current use of antidepressants or opioids.
- Lifetime diagnosis of anorexia nervosa or bulimia nervosa
- Lifetime alcohol or substance abuse disorder or dependence
- Suicidal ideation in past year
- Lifetime serious head injury or stroke judged to impact pain or sleep
- Sleep disorder as assessed via the Structured Interview for sleep disorders (SIS-D).
- Women who are pregnant or lactating.
- Unwilling to follow study procedures
- Other (reason judged by PI)
- Food allergies: Individuals who report any food allergies or any history of anaphylactic reactions related to study procedures during the phone screen for this study will be excluded from participation. Participants who report avoidance of specific foods for other medical reasons (e.g., an interaction between a prescribed medication and a food group, food triggered migraines), if they are related to study procedures, will also be excluded from participation.
- Takes participant more than 30 minutes to fall asleep
- Positive toxicology screen
Sites / Locations
- Johns Hopkins University Bayview Campus, Behavioral Medicine Research Lab
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Sham Comparator
Sham Comparator
Approach/Inhibit group
Sham sound cues group
Sham go/no-go group
Participants in the experimental group and control sham sound cues group will complete the Modified Go/No-Go Task. Following completion of post-training assessment measures, participants will be given the opportunity to take a 90-minute while undergoing real-time sleep monitoring. White noise will be played via headphones. Upon entering Stage N3 sleep and/or after having been asleep for 20 minutes and currently in any stage sleep other than N1, sound cues will be played to participants via headphones based on their randomization to 1 of 3 experimental groups.
Participants in the experimental group and control sham sound cues group will complete the Modified Go/No-Go Task. Following completion of post-training assessment measures, participants will be given the opportunity to take a 90-minute while undergoing real-time sleep monitoring. White noise will be played via headphones. Upon entering Stage N3 sleep and/or after having been asleep for 20 minutes and currently in any stage sleep other than N1, sound cues will be played to participants via headphones based on their randomization to 1 of 3 experimental groups.
Participants in the control sham go/no-go group will complete a modified Go/No-Go Task with sham approach and inhibit items. Following completion of post-training assessment measures, participants will be given the opportunity to take a 90-minute while undergoing real-time sleep monitoring. White noise will be played via headphones. Upon entering Stage N3 sleep and/or after having been asleep for 20 minutes and currently in any stage sleep other than N1, sound cues will be played to participants via headphones based on their randomization to 1 of 3 experimental groups.